Damian Marron

Président chez NICOX SA Fortune : 9 630 $ au 30/09/2026

Profil

Dr. Damian Marron is a Chairman at Nicox SA, a Chairman at Circio Holding ASA, a Chairman at Indegra Therapeutics Ltd., a Chairman at Onya Therapeutics Ltd., a Head-Biopharma at Treehill Partners, LLC and a Non-Executive Chairman at Hone Bio Ltd. He is on the Board of Directors at Cantargia AB, Resolys Bio, Inc., Agalimmune Ltd. and Loxbridge Research LLP.
Dr. Marron was previously employed as an Independent Non-Executive Director by Bone Therapeutics SA, a Chief Executive Officer & Director by TxCell SA, a Chief Executive Officer by Trophos SA, a Head-European Business Development by Bausch & Lomb (Australia) Pty Ltd., a Director-Clinical Operations by Rhone-Poulenc Rorer BV, a Clinical Research Associate by Glaxo Wellcome Immobilière de Recherche SA, a Non-Executive Chairman by Cytheris SA, a Non-Executive Chairman by Imophoron Ltd., a Manager-Drug Group by Orphan Europe SARL, and a Chairman by PepGen Ltd. He also served on the board at France Biotech Association and Theralpha.
He received his undergraduate degree from The University of Liverpool.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
CANTARGIA AB 0,02 %	31/12/2025	63 054 ( 0,02 % )	9 630 $	30/09/2026

Postes actifs de Damian Marron

Sociétés	Poste	Début
CIRCIO HOLDING ASA	Président	29/04/2020
CANTARGIA AB	Directeur/Membre du Conseil	26/05/2021
NICOX SA	Président	16/07/2024
Agalimmune Ltd.	Directeur/Membre du Conseil	-
Cytoseek Ltd.	Président	-
Treehill Partners, LLC	Corporate Officer/Principal	-
Resolys Bio, Inc.	Directeur/Membre du Conseil	01/03/2018
Loxbridge Research LLP	Directeur/Membre du Conseil	-

Anciens postes connus de Damian Marron

Sociétés	Poste	Fin
TXCELL	Directeur Général	28/04/2015
░░░░░░░ ░░	░░░░░░░░░ ░░░░░░░░░	-
░░░░░ ░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░░ ░░░░░ ░░░░ ░░░░░░░░░░░ ░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-
░░░░░░ ░░░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-